Haematologica (Feb 2023)
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival
- Maymona G. Abdelmagid,
- Aref Al-Kali,
- Kebede H. Begna,
- William J. Hogan,
- Mark R. Litzow,
- Farah Fleti,
- Abhishek A. Mangaonkar,
- Mrinal S. Patnaik,
- Michelle A. Elliott,
- Hassan Alkhateeb,
- Min Shi,
- Matthew T. Howard,
- Kaaren K. Reichard,
- Rhett P. Ketterling,
- Mithun Shah,
- Animesh Pardanani,
- Naseema Gangat,
- Ayalew Tefferi
Affiliations
- Maymona G. Abdelmagid
- Divisions of Hematology and Medicine
- Aref Al-Kali
- Divisions of Hematology and Medicine
- Kebede H. Begna
- Divisions of Hematology and Medicine
- William J. Hogan
- Divisions of Hematology and Medicine
- Mark R. Litzow
- Divisions of Hematology and Medicine
- Farah Fleti
- Divisions of Hematology and Medicine
- Abhishek A. Mangaonkar
- Divisions of Hematology and Medicine
- Mrinal S. Patnaik
- Divisions of Hematology and Medicine
- Michelle A. Elliott
- Divisions of Hematology and Medicine
- Hassan Alkhateeb
- Divisions of Hematology and Medicine
- Min Shi
- Divisions of Hematopathology, Departments of Laboratory Medicine, Mayo Clinic, Rochester, MN
- Matthew T. Howard
- Divisions of Hematopathology, Departments of Laboratory Medicine, Mayo Clinic, Rochester, MN
- Kaaren K. Reichard
- Divisions of Hematopathology, Departments of Laboratory Medicine, Mayo Clinic, Rochester, MN
- Rhett P. Ketterling
- Divisions of Hematopathology, Departments of Laboratory Medicine, Mayo Clinic, Rochester, MN
- Mithun Shah
- Divisions of Hematology and Medicine
- Animesh Pardanani
- Divisions of Hematology and Medicine
- Naseema Gangat
- Divisions of Hematology and Medicine
- Ayalew Tefferi
- Divisions of Hematology and Medicine
- DOI
- https://doi.org/10.3324/haematol.2022.282627
- Journal volume & issue
-
Vol. 108,
no. 9
Abstract
No abstracts available.
